Tonka
Well-known member
http://www.oem.com.mx/eloccidental/notas/n1823464.htm
Guadalajara
Jalisco remains on alert for dengue, conjunctivitis and influenza
Occidental
October 19, 2010
Isaura Lopez Villalobos
Guadalajara, Jalisco .- Once again dengue, influenza A H3N2 and hemorrhagic conjunctivitis kept in suspense the health authorities in Jalisco, who have seen cases exceeded previously established by the specialists.
A little over two months of the end of the year on dengue entity reaches a thousand people affected, however the cases are down compared to the same period last year.
Regarding hemorrhagic conjunctivitis, statistics amounts to 5,001 people affected, with the municipalities of Puerto Vallarta, Zapotl?n de Vadillo, Toliman, Jilotl?n of Sorrows and the Guadalajara metropolitan area most affected. And to date, influenza A H3N2, 21 people have reported signs and symptoms of strain that will affect the Mexican population in the coming winter months, but will start on October 25 when the vaccine is being applied various sectors of the population.
***
Jalisco increases in cases of influenza H3N2 to date, 21 people have been sickened by the virus will affect the Mexican population in the coming winter months, however, the application of the vaccine will be from 25 October.
The head of Epidemiology at the Ministry of Health, Lucia Salazar Montes, reported that the majority was made in the Guadalajara metropolitan area, reported that to date most favorable evolves as it has been applied in a timely treatment "This is the same as applied for (influenza) H1N1, oseltamivir (viral drug)."
He said it is a "responsibility" of each of the health institutions have the medicine, some of the symptoms of H3N3 influenza is a respiratory process coupled to attack the patient's general condition (cough, runny nose, headache, sore throat and fever).
With regard to the application of vaccines against seasonal human influenza, the director general of Public Health, Mario Marquez Amezcua, reported next week to begin the implementation of biological expected that both the Mexican Social Security Institute as ISSSTE receive their allocations to launch the vaccination campaign.
Since last Friday, the Ministry of Health received about 160 thousand seasonal influenza vaccines, priority groups for the implementation of the doses are children six months to four years from five to nine years who are vaccinated risk factors and adults with respiratory problems, heart and kidney.
The seasonal flu virus appears in October and November, but this year the cases were reported since September, and Jalisco accumulates 21 infections so far.
The vaccine is protective for the two types of influenza: seasonal, represented by the H3N2 strain, and human (A-H1N1), which caused a pandemic last year.
The priority areas for immediate application of biological be areas where low temperatures so arrive early, as in the North and the Valleys region.
Guadalajara
Jalisco remains on alert for dengue, conjunctivitis and influenza
Occidental
October 19, 2010
Isaura Lopez Villalobos
Guadalajara, Jalisco .- Once again dengue, influenza A H3N2 and hemorrhagic conjunctivitis kept in suspense the health authorities in Jalisco, who have seen cases exceeded previously established by the specialists.
A little over two months of the end of the year on dengue entity reaches a thousand people affected, however the cases are down compared to the same period last year.
Regarding hemorrhagic conjunctivitis, statistics amounts to 5,001 people affected, with the municipalities of Puerto Vallarta, Zapotl?n de Vadillo, Toliman, Jilotl?n of Sorrows and the Guadalajara metropolitan area most affected. And to date, influenza A H3N2, 21 people have reported signs and symptoms of strain that will affect the Mexican population in the coming winter months, but will start on October 25 when the vaccine is being applied various sectors of the population.
***
Jalisco increases in cases of influenza H3N2 to date, 21 people have been sickened by the virus will affect the Mexican population in the coming winter months, however, the application of the vaccine will be from 25 October.
The head of Epidemiology at the Ministry of Health, Lucia Salazar Montes, reported that the majority was made in the Guadalajara metropolitan area, reported that to date most favorable evolves as it has been applied in a timely treatment "This is the same as applied for (influenza) H1N1, oseltamivir (viral drug)."
He said it is a "responsibility" of each of the health institutions have the medicine, some of the symptoms of H3N3 influenza is a respiratory process coupled to attack the patient's general condition (cough, runny nose, headache, sore throat and fever).
With regard to the application of vaccines against seasonal human influenza, the director general of Public Health, Mario Marquez Amezcua, reported next week to begin the implementation of biological expected that both the Mexican Social Security Institute as ISSSTE receive their allocations to launch the vaccination campaign.
Since last Friday, the Ministry of Health received about 160 thousand seasonal influenza vaccines, priority groups for the implementation of the doses are children six months to four years from five to nine years who are vaccinated risk factors and adults with respiratory problems, heart and kidney.
The seasonal flu virus appears in October and November, but this year the cases were reported since September, and Jalisco accumulates 21 infections so far.
The vaccine is protective for the two types of influenza: seasonal, represented by the H3N2 strain, and human (A-H1N1), which caused a pandemic last year.
The priority areas for immediate application of biological be areas where low temperatures so arrive early, as in the North and the Valleys region.